ThyGeNEXT + ThyraMIR v2
Combined NGS mutation/fusion and microRNA classifier workflow for indeterminate thyroid nodules.
- Developer
- Interpace Biosciences
- Intended use
- Diagnostic Aid
- Cancer scope
- Not reported
- Specimen
- Thyroid fine-needle aspirate
- Molecular modality
- DNA mutation, RNA expression
- Current version
- ThyGeNEXT + ThyraMIR v2 current combined workflow (2026)
- Evidence context
- 1 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.